Jianping Chen
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
-
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- Cancer-related Molecular Pathways 2
-
- Liver physiology and pathology 1
- Co-authors
- Bin Wang (1 shared paper)Qian Qian (2 shared papers)Changping Wu (2 shared papers)Jingting Jiang (1 shared paper)Wei A. He (1 shared paper)Jing Yang (1 shared paper)Jiajie Luan (1 shared paper)Yangyang Yu (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (1 paper)American Journal of Dermatopathology (1 paper)OncoImmunology (1 paper)Journal of Pharmacological Sciences (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jianping Chen
17 papers receiving 493 citations
Peers
Comparison fields: 5 of 57
- Oncology 133
- Cancer Research 63
- Molecular Biology 223
- Hematology 25
- Pharmacology 26
Countries citing papers authored by Jianping Chen
This map shows the geographic impact of Jianping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Chen more than expected).
Fields of papers citing papers by Jianping Chen
This network shows the impact of papers produced by Jianping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Chen. The network helps show where Jianping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. | 1998 | 272 |
| 2 | 2012 | 43 | |
| 3 | 2018 | 40 | |
| 4 | 2016 | 38 | |
| 5 | Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models. | 1999 | 32 |
| 6 | 2006 | 22 | |
| 7 | Function and subsets of dendritic cells and natural killer cells were decreased in gastric cancer. | 2014 | 21 |
| 8 | 2020 | 15 | |
| 9 | 2015 | 14 | |
| 10 | 2020 | 14 | |
| 11 | 2008 | 8 | |
| 12 | 2019 | 8 | |
| 13 | 2021 | 8 | |
| 14 | 2022 | 7 | |
| 15 | 2015 | 6 | |
| 16 | 2008 | 5 | |
| 17 | 2008 | 2 | |
| 18 | 2025 | 0 |
About Jianping Chen
Jianping Chen is a scholar working on Oncology, Hepatology, Molecular Biology, Immunology and Rehabilitation, having authored 18 papers that have together received 555 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Cancer-related Molecular Pathways (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Glycosylation and Glycoproteins Research (2 papers), Gastroesophageal reflux and treatments (1 paper), Melanoma and MAPK Pathways (1 paper), Liver physiology and pathology (1 paper) and Berberine and alkaloids research (1 paper). The work is most often cited by research in Oncology (133 citations), Cancer Research (63 citations), Molecular Biology (223 citations), Hematology (25 citations) and Pharmacology (26 citations). Jianping Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bin Wang, Qian Qian, Changping Wu, Jingting Jiang, Wei A. He, Jing Yang, Jiajie Luan, Yangyang Yu, Longfei Li and Jia Cao. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, American Journal of Dermatopathology, OncoImmunology, Journal of Pharmacological Sciences and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.